UK Transparency Hub
← Back

NHS National Framework Agreement for the Supply of Adalimumab

Awarded by NHS England · 2018-09-19T17:53:04+01:00 · £560,000,000

Description

for NHS National Framework Agreement for Adalimumab Injection, Framework Period: 1 December 2018 - 30 November 2019 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months Tender Reference: CM/PHR/18/5567

Buyer
NHS England
Value
£560,000,000
Category (CPV)
Pharmaceutical products
Award date
2018-09-19T17:53:04+01:00
Buyer constituency
runcorn-and-helsby

Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.

Loading…
Loading…